Olumiant is marked as the first and only systemic medicine for severe AA adult patients. It is an oral and once-daily JAK inhibitor which is available through specialty
The post Eli Lilly, Incyte receive FDA approval for severe alopecia areata medicine appeared first on Pharmaceutical Business review.